Ireland
--:--IST
Starting soon Observational

Regional Ventilation Evaluation During Neuro-injury Weaning Study

NCT07067671 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2026-03
Last updated
2026-02-19

Condition(s) studied

Acute Brain InjuryMechanical VentilationProlonged WeaningTraumatic Brain InjuryHypoxic-Ischemic Brain InjuryIntracerebral Hemorrhage

Investigational drug(s) / intervention(s)

Internal Thoracic Impedance

Internal Thoracic Impedance: Internal Thoracic Impedance is a non-invasive an imaging technique which use low alternative current through electrodes placed on a belt positioned at the level of the patient's rib cage. Images are constructed according to conductivity measured.

Study summary

This study evaluates changes in regional lung ventilation using thoracic electrical impedance tomography (EIT) during the weaning process from mechanical ventilation in ICU patients with acute brain injury. It aims to identify predictive EIT patterns related to extubation outcomes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age 18 or older * Hospitalized in intensive care for an acute brain injury. * Mechanical ventilation for more than 48 hours. * Ventilator withdrawal planned in the next few days * Social security coverage Exclusion Criteria: * Pregnancy * Moribund patient / decision to stop treatment * Patient under state medical aid

Primary outcome measure(s)

  • Absolute ventral-to-dorsal ventilation difference — From the start of the ventilator mode change or spontaneous breathing trial until 30 minutes after.
    The Absolute V-D Difference will be calculated as the average of the ventilation in the ventral regions (ROI1 and ROI2) minus the average of the ventilation in the dorsal regions (ROI3 and ROI4) during mechanical ventilation weaning. This outcome will provide insights into regional pulmonary ventilation distribution and its correlation with extubation outcomes. This difference is calculated as follows: (ROI\_Value1 + ROI\_Value2)/2 - (ROI\_Value3 + ROI\_Value4)/2 expressed as a percentage.

Trial sites (1)

FacilityCityRegionStatus
Hôpital Lariboisière - APHP Paris France
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07067671 on ClinicalTrials.gov ↗ ← All trials in France